EXPE three-lens brief
Evidence-based stock research on EXPE. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Moved -2.75% yesterday. · Underperforming SPY by 20.0pp over 30 days.
- Moved -2.75% yesterday.
- Underperforming SPY by 20.0pp over 30 days.
- Analyst mean target $286.33 — 33% above current (33 analysts).
- Debt-to-equity of 256.5 — balance-sheet-heavy.
EXPE closed at $215.40 (-2.75%) as of 2026-05-13. Market cap: $25.85B. P/E (trailing) 19.0. Positives: analyst mean target $286.33 — 33% above current (33 analysts).. Concerns: moved -2.75% yesterday.; underperforming SPY by 20.0pp over 30 days.. Last quarter: Revenue $3.43B, net income -$6.00M, free cash flow $3.48B.
Why three lenses on EXPE, not one.
A single reasoning model has blind spots it doesn’t know about. We examine EXPEacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/EXPE" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath EXPE brief"></iframe>